| MeSH term | MeSH ID | Detail |
|---|---|---|
| Congenital Abnormalities | D000013 | 11 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Anemia | D000740 | 21 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Asthma | D001249 | 52 associated lipids |
| Ataxia Telangiectasia | D001260 | 6 associated lipids |
| Birth Weight | D001724 | 23 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
| Burkitt Lymphoma | D002051 | 15 associated lipids |
CYTOCHALASIN B
CYTOCHALASIN B is a lipid of Polyketides (PK) class. Cytochalasin b is associated with abnormalities such as Renal tubular disorder and Chagas Disease. The involved functions are known as Membrane Protein Traffic, inhibitors, Metabolic Inhibition, Biochemical Pathway and Increased Sensitivy. Cytochalasin b often locates in Cytoplasmic matrix, Plasma membrane, Microtubules, Extracellular and Protoplasm. The associated genes with CYTOCHALASIN B are SLC2A2 gene, PFDN5 gene, SLC2A1 gene, OMG gene and SPEN gene. The related lipids are Steroids, Lipopolysaccharides and Liposomes. The related experimental models are Xenograft Model.
Cross Reference
Introduction
To understand associated biological information of CYTOCHALASIN B, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with CYTOCHALASIN B?
CYTOCHALASIN B is suspected in Renal tubular disorder, Chagas Disease and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with CYTOCHALASIN B
PubChem Associated disorders and diseases
What pathways are associated with CYTOCHALASIN B
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with CYTOCHALASIN B?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with CYTOCHALASIN B?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with CYTOCHALASIN B?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with CYTOCHALASIN B?
Related references are published most in these journals:
- Am. J. Physiol., Cell Physiol. (2)
- Am. J. Physiol. Endocrinol. Metab. (1)
- Am. J. Physiol. Gastrointest. Liver Physiol. (1)
- Others (8)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with CYTOCHALASIN B?
Xenograft Model
Xenograft Model are used in the study 'Endofacial competitive inhibition of the glucose transporter 1 activity by gossypol.' (Pérez A et al., 2009).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with CYTOCHALASIN B
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Russo MA et al. | Ultrastruct pathology of phalloidin-intoxicated hepatocytes in the presence and absence of extracellular calcium. | 1982 | Am. J. Pathol. | pmid:6890315 |
| Fantone JC et al. | Stimulus specificity of prostaglandin inhibition of rabbit polymorphonuclear leukocyte lysosomal enzyme release and superoxide anion production. | 1984 | Am. J. Pathol. | pmid:6324595 |
| Wysolmerski RB and Lagunoff D | Inhibition of endothelial cell retraction by ATP depletion. | 1988 | Am. J. Pathol. | pmid:3394800 |
| Sayós J et al. | Regulation of nitrobenzylthioninosine-sensitive adenosine uptake by cultured kidney cells. | 1994 | Am. J. Physiol. | pmid:7977779 |
| Mullin JM et al. | Isolation of mutant renal (LLC-PK1) epithelia defective in basolateral, Na(+)-independent glucose transport. | 1989 | Am. J. Physiol. | pmid:2603953 |
| Mattana J and Singhal PC | Macrophage Fc receptor activity modulates mesangial cell proliferation and matrix synthesis. | 1994 | Am. J. Physiol. | pmid:8184889 |
| Goodyear LJ et al. | Glucose transporter number, activity, and isoform content in plasma membranes of red and white skeletal muscle. | 1991 | Am. J. Physiol. | pmid:1951679 |
| Goodyear LJ et al. | Exercise-induced translocation of skeletal muscle glucose transporters. | 1991 | Am. J. Physiol. | pmid:1662910 |
| Fürnsinn C et al. | More marked stimulation by lithium than insulin of the glycogenic pathway in rat skeletal muscle. | 1997 | Am. J. Physiol. | pmid:9316440 |
| Henquin JC and Lambert AE | Bicarbonate modulation of glucose-9nduced biphasic insulin release by rat islets. | 1976 | Am. J. Physiol. | pmid:788525 |